This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name miRBase accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
bta-let-7gMIMAT0003838 0.0e+0 3.0e-1Grazing Affects Exosomal Circulating MicroRNAs in Cattle.
PLoS One. 2015 Aug 26;10(8):e0136475. doi: 10.1371/journal.pone.0136475. eCollection 2015.		MIPF0000002_1115 / 0 / 115
bta-let-7iMIMAT0003851 0.0e+0 3.8e-1Grazing Affects Exosomal Circulating MicroRNAs in Cattle.
PLoS One. 2015 Aug 26;10(8):e0136475. doi: 10.1371/journal.pone.0136475. eCollection 2015.		MIPF0000002_1115 / 0 / 115
bta-let-7a-5pMIMAT0003844 0.0e+0 2.1e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7bMIMAT0004331 0.0e+0 3.7e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7cMIMAT0004332 0.0e+0 7.0e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7dMIMAT0003810 0.0e+0 6.8e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7eMIMAT0004333 0.0e+0 1.8e-1Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7fMIMAT0003519 0.0e+0 2.0e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7gMIMAT0003838 0.0e+0 3.7e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7iMIMAT0003851 0.0e+0 5.5e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7a-5pMIMAT0003844 0.0e+0 4.6e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7bMIMAT0004331 0.0e+0 6.9e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7cMIMAT0004332 0.0e+0 1.3e-1Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7dMIMAT0003810 0.0e+0 1.0e-1Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7fMIMAT0003519 0.0e+0 4.3e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7gMIMAT0003838 0.0e+0 6.5e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
bta-let-7iMIMAT0003851 0.0e+0 8.2e-2Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000002_1115 / 0 / 115
hsa-let-7d-5pMIMAT0000065 0.0e+0 1.4e-1Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing.
RNA Biol. 2016 Oct 28:0.		MIPF0000002_1115 / 0 / 115
hsa-let-7f-5pMIMAT0000067 0.0e+0 2.0e-1Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing.
RNA Biol. 2016 Oct 28:0.		MIPF0000002_1115 / 0 / 115
hsa-let-7a-5pMIMAT0000062 0.0e+0 9.7e-4Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7b-5pMIMAT0000063 0.0e+0 5.0e-3Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7c-5pMIMAT0000064 0.0e+0 3.9e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7d-5pMIMAT0000065 0.0e+0 4.0e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7e-5pMIMAT0000066 0.0e+0 2.2e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7f-5pMIMAT0000067 0.0e+0 2.0e-3Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7g-5pMIMAT0000414 0.0e+0 8.4e-3Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7i-5pMIMAT0000415 0.0e+0 1.6e-3Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-miR-98-5pMIMAT0000096 0.0e+0 4.4e-1Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7a-5pMIMAT0000062 0.0e+0 9.1e-3Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7b-5pMIMAT0000063 0.0e+0 1.7e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7c-5pMIMAT0000064 0.0e+0 3.6e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7d-5pMIMAT0000065 0.0e+0 5.0e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7e-5pMIMAT0000066 0.0e+0 7.0e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7f-5pMIMAT0000067 0.0e+0 1.2e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7g-5pMIMAT0000414 0.0e+0 4.0e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-let-7i-5pMIMAT0000415 0.0e+0 3.8e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
hsa-miR-98-5pMIMAT0000096 0.0e+0 2.0e-1Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000002_1115 / 0 / 115
bta-let-7bMIMAT0004331 0.0e+0 1.5e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
bta-let-7dMIMAT0003810 0.0e+0 3.9e-2Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
cbr-let-7MIMAT0000463 0.0e+0 3.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
cel-let-7-5pMIMAT0000001 0.0e+0 3.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
cfa-let-7aMIMAT0006594 0.0e+0 3.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
cfa-let-7cMIMAT0006669 0.0e+0 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
gga-let-7bMIMAT0001102 0.0e+0 1.5e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
gga-let-7j-5pMIMAT0001181 0.0e+0 3.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
mml-let-7a-5pMIMAT0006151 0.0e+0 3.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
mml-let-7b-5pMIMAT0006152 0.0e+0 1.5e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
mml-let-7c-5pMIMAT0006153 0.0e+0 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
mml-let-7dMIMAT0006154 0.0e+0 3.9e-2Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
mml-let-7i-5pMIMAT0006158 0.0e+0 1.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
oan-let-7b-5pMIMAT0006897 0.0e+0 1.5e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
oan-let-7d-5pMIMAT0007234 0.0e+0 3.9e-2Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
ptr-let-7aMIMAT0007936 0.0e+0 3.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
ptr-let-7bMIMAT0007937 0.0e+0 1.5e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
ptr-let-7cMIMAT0007938 0.0e+0 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
ptr-let-7dMIMAT0007939 0.0e+0 3.9e-2Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
ptr-let-7iMIMAT0007943 0.0e+0 1.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
ssc-let-7cMIMAT0002151 0.0e+0 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
xtr-let-7aMIMAT0003667 0.0e+0 3.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
xtr-let-7cMIMAT0003644 0.0e+0 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
cbr-let-7MIMAT0000463 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
cel-let-7-5pMIMAT0000001 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
cfa-let-7aMIMAT0006594 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
cin-let-7eMIMAT0006090 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
gga-let-7j-5pMIMAT0001181 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
hsa-let-7b-5pMIMAT0000063 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
mml-let-7a-5pMIMAT0006151 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
mmu-miR-98-5pMIMAT0000545 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
ptr-let-7aMIMAT0007936 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
rno-miR-98-5pMIMAT0000819 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
xtr-let-7aMIMAT0003667 1.0e-3 1.0e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000002_1115 / 0 / 115
hsa-let-7a-5pMIMAT0000062 0.0e+0 4.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7a-5pMIMAT0000062 0.0e+0 3.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7b-5pMIMAT0000063 0.0e+0 3.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7b-5pMIMAT0000063 0.0e+0 4.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7f-5pMIMAT0000067 0.0e+0 3.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7f-5pMIMAT0000067 0.0e+0 4.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7g-5pMIMAT0000414 0.0e+0 4.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7i-5pMIMAT0000415 0.0e+0 3.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7i-5pMIMAT0000415 0.0e+0 2.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7a-5pMIMAT0000062 0.0e+0 4.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7a-5pMIMAT0000062 0.0e+0 3.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7f-5pMIMAT0000067 0.0e+0 4.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7i-5pMIMAT0000415 0.0e+0 4.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
hsa-let-7i-5pMIMAT0000415 0.0e+0 4.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000002_1115 / 0 / 115
mmu-let-7a-5pMIMAT0000521 0.0e+0 3.2e-9Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7b-5pMIMAT0000522 0.0e+0 5.1e-14Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7c-5pMIMAT0000523 0.0e+0 1.1e-11Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7d-5pMIMAT0000383 0.0e+0 1.0e-7Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7e-5pMIMAT0000524 0.0e+0 2.0e-7Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7f-5pMIMAT0000525 0.0e+0 3.0e-7Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7g-5pMIMAT0000121 0.0e+0 4.2e-6Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7i-5pMIMAT0000122 0.0e+0 6.2e-6Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-miR-98-5pMIMAT0000545 0.0e+0 1.5e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7a-5pMIMAT0000521 0.0e+0 3.2e-4Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7c-5pMIMAT0000523 0.0e+0 5.2e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7d-5pMIMAT0000383 0.0e+0 1.3e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7e-5pMIMAT0000524 0.0e+0 3.1e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7f-5pMIMAT0000525 0.0e+0 4.8e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
mmu-let-7g-5pMIMAT0000121 0.0e+0 1.0e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000002_1115 / 0 / 115
< [17] [18] [19] [20]